The debt of 10x Genomics, Inc. over the past 9 years
Chart 10x Genomics, Inc.: liquid cash, total debt, net cash, fiscal 2017–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, 10x Genomics, Inc. had liquid cash of $523.41M and total debt of $0: net cash of $523.41M. It had more liquid cash than debt at all 8 year-ends shown. Total debt was highest at the end of fiscal 2019 ($29.72M) and lowest at the end of fiscal 2020 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $523.41M* | $0 | $523.41M |
| 2024ended Dec 31, 2024 | $393.4M* | $0 | $393.4M |
| 2023ended Dec 31, 2023 | $388.69M* | $0 | $388.69M |
| 2022ended Dec 31, 2022 | $429.98M* | $0 | $429.98M |
| 2021ended Dec 31, 2021 | $587.45M* | $0 | $587.45M |
| 2020ended Dec 31, 2020 | $663.6M | $0 | $663.6M |
| 2019ended Dec 31, 2019 | $424.17M | $29.72M | $394.45M |
| 2018ended Dec 31, 2018 | $65.08M | $29.68M | $35.4M |
| 2017ended Dec 31, 2017 | — | — | — |
Fiscal years as 10x Genomics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on 10x Genomics, Inc.
- The revenue of 10x Genomics, Inc.
- The profitability of 10x Genomics, Inc.
- The cash flow of 10x Genomics, Inc.
- All of 10x Genomics, Inc.'s financials, charted
Companies of a similar size
- HNGEHinge Health, Inc.
- DRSLeonardo DRS, Inc.
- HLHECLA MINING CO/DE/
- PBFPBF ENERGY INC.
- BAHBooz Allen Hamilton Holding Corporation
Not investment advice. This page shows what 10x Genomics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.